Trials / Unknown
UnknownNCT00892918
Effect of Moxifloxacin Versus Gatifloxacin on Corneal Epithelium Following Pterygium Excision
A Randomized Clinical Trial Comparing the Effect of Moxifloxacin Versus Gatifloxacin Following Pterygium Excision on Corneal Epithelial Healing and Epithelial Toxicity.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Meir Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether there is a difference in corneal epithelial healing rate and/or toxicity following pterygium excision, between eyes treated post-operatively by moxifloxacin(VIGAMOX)versus gatifloxacin (ZYMAR).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Moxifloxacin ophthalmic solution 0.5% ; Gatifloxacin ophthalmic solution 0.3% | Each drug will be given 4 times a day, 1 drop each time to the operated eye, for 21 days. |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2009-05-05
- Last updated
- 2009-05-05
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00892918. Inclusion in this directory is not an endorsement.